The Lancet Oncology in conversation with
The Lancet Group
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.
All episodes
Best episodes
Top 10 The Lancet Oncology in conversation with Episodes
Goodpods has curated a list of the 10 best The Lancet Oncology in conversation with episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to The Lancet Oncology in conversation with for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite The Lancet Oncology in conversation with episode by adding your comments to the episode page.
Ariana Znaor on cancer surveillance in the Eastern Mediterranean region
The Lancet Oncology in conversation with
03/03/25 • 20 min
Ariana Znaor (Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France) discusses her Review on cancer surveillance in the Eastern Mediterranean Region: a 10-year IARC-WHO EMRO collaboration.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Cancer survivorship in the USA: The Lancet Oncology: 30 December
The Lancet Oncology in conversation with
12/30/16 • 11 min
Ann Partridge talks about cancer survival in the USA.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet Oncology: May 02, 2014
The Lancet Oncology in conversation with
05/02/14 • 9 min
Ian Krop discusses a phase III trial to assess efficacy of trastuzumab emtansine for women with recurrent HER2-positive breast cancer.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma
The Lancet Oncology in conversation with
07/03/23 • 33 min
Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00246-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
James Glasbey on the effect of lockdowns on cancer surgery
The Lancet Oncology in conversation with
11/01/21 • 7 min
James Glasbey (UK NIHR Global Health Research Unit on Global Surgery, University of Birmingham, Birmingham, UK) discusses his Article on the effect of COVID-19 pandemic lockdowns on planned cancer surgery.
Read the full paper:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00493-9/fulltext
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet Oncology: September 17, 2014
The Lancet Oncology in conversation with
09/17/14 • 6 min
Daniel M Green discusses the effect of treatment for childhood cancers on male fertility.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet Oncology: March 19, 2014
The Lancet Oncology in conversation with
03/19/14 • 11 min
Michael Höckel joins Natalie Harrison to discuss how surgery based on ontogenetic staging is sufficient to control cervical cancer without additional radiotherapy.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet Oncology: September 26, 2011
The Lancet Oncology in conversation with
09/26/11 • 51 min
David Collingridge launches The Lancet Oncology Commission on delivering affordable cancer care in high-income countries.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
The Lancet Oncology: May 27, 2011
The Lancet Oncology in conversation with
05/27/11 • 7 min
June issue highlights, including faecal blood tests to assess future colorectal cancer risk, and of the 'dangerous liaison' between cancer and tuberculosis.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations
The Lancet Oncology in conversation with
06/24/24 • 36 min
Dr Hisham Mehanna (University of Birmingham, Birmingham, UK) and Dr Sue Yom (University of California, San Francisco, San Francisco, CA, USA) discuss their four-paper Series on Head and Neck Cancer Consensus Recommendations in diagnosis and clinical trial endpoints.
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
Show more best episodes
Show more best episodes
FAQ
How many episodes does The Lancet Oncology in conversation with have?
The Lancet Oncology in conversation with currently has 209 episodes available.
What topics does The Lancet Oncology in conversation with cover?
The podcast is about Life Sciences, Health & Fitness, Cancer, Medicine, Podcasts and Science.
What is the most popular episode on The Lancet Oncology in conversation with?
The episode title 'Mark Lawler and Richard Sullivan on the European Groundshot' is the most popular.
What is the average episode length on The Lancet Oncology in conversation with?
The average episode length on The Lancet Oncology in conversation with is 13 minutes.
How often are episodes of The Lancet Oncology in conversation with released?
Episodes of The Lancet Oncology in conversation with are typically released every 29 days, 1 hour.
When was the first episode of The Lancet Oncology in conversation with?
The first episode of The Lancet Oncology in conversation with was released on Feb 25, 2008.
Show more FAQ
Show more FAQ